IX Biopharma Company Announcements (42C)

SGX Google Yahoo News TradingView

IX BIOPHARMA LTD. (42C) SGD 0.125 +2.40% +0.00

Portfolio Watchlist

All Financial Buy Back Insider Trading

2022-01-09

General Announcement::WAFERMINE LICENSING TRANSACTION - RECEIPT OF UPFRONT PAYMENT

2021-12-06

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Notification Form for Director in respect of Interests in Securities - Eddy Lee Yip Hang

2021-12-06

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Notification Form for Director in respect of Interests in Securities - Albert Ho Shing Tung

2021-11-29

Annual Reports and Related Documents::

2021-11-24

General Announcement::EXCLUSIVE LICENSE AGREEMENT FOR WAFERMINE AND OTHER SUBLINGUAL KETAMINE WAFER PRODUCTS

2021-11-24

Request for Lifting of Trading Halt::Request for Lifting of Trading Halt

2021-11-24

General Announcement::REQUEST FOR LIFTING OF TRADING HALT - SPONSOR'S STATEMENT

2021-11-23

Request for Trading Halt::Request for Trading Halt

2021-11-22

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Notification Form for Director in respect of Interests in Securities - Eddy Lee Yip Hang

2021-11-22

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Notification Form for Director in respect of Interests in Securities - Albert Ho Shing Tung

2021-11-21

Employee Stock Option/ Share Scheme::GRANT OF SHARE AWARDS PURSUANT TO iX PERFORMANCE SHARE PLAN

2021-10-27

General Announcement::CHANGES IN THE COMPOSITION OF THE BOARD AND BOARD COMMITTEES

2021-10-26

General Announcement::Minutes of Annual General Meeting held on 15 October 2021

2021-10-25

General Announcement::iX Biopharma Expands Nutraceuticals Portfolio With Innovative Anti-Aging Sublingual NAD+ Product

2021-10-15

REPL::Annual General Meeting::Voluntary

2021-10-14

General Announcement::QUESTIONS AND ANSWERS PROVIDED AHEAD OF THE UPCOMING AGM TO BE HELD ON 15 OCTOBER 2021

2021-09-29

General Announcement::iX Biopharma Signs Wafesil Licensing Agreement with China Resources Pharmaceutical Commercial Group

2021-09-29

Change - Announcement of Cessation::Retirement of Independent Non-Executive Director - Claudia Teo Kwee Yee

2021-09-28

Annual General Meeting::Voluntary

2021-09-28

Annual Reports and Related Documents::

2021-08-23

Financial Statements and Related Announcement::Full Yearly Results

2021-07-27

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Notification Form for Director in respect of Interests in Securities - Eddy Lee Yip Hang

2021-07-27

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Notification Form for Director in respect of Interests in Securities - Albert Ho Shing Tung

2021-07-27

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Notification Form for Director in respect of Interests in Securities - Teo Kwee Yee

2021-07-27

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Notification Form for Director in respect of Interests in Securities - Low Weng Keong

2021-07-26

General Announcement::Press Release: iX Biopharma to Export Sublingual Medicinal Cannabis Wafer to New Zealand

2021-07-25

General Announcement::RESULTS OF THE RIGHTS ISSUE AND LISTING AND QUOTATION OF THE RIGHTS SHARES

2021-07-16

Employee Stock Option/ Share Scheme::GRANT OF SHARE OPTION PURSUANT TO iX EMPLOYEE SHARE OPTION SCHEME

2021-07-11

General Announcement::PROPOSED SPIN-OFF AND LISTING OF PHARMACEUTICAL AND MEDICINAL CANNABIS BUSINESS ON THE HKEX

2021-07-06

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Notification Form for Director in respect of Interests in Securities - Eddy Lee Yip Hang

2021-07-06

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Notification Form for Director in respect of Interests in Securities - Albert Ho Shing Tung

2021-07-06

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Notification Form for Director in respect of Interests in Securities - Low Weng Keong

2021-07-06

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Notification Form for Director in respect of Interests in Securities - Teo Kwee Yee

2021-07-05

General Announcement::RIGHTS ISSUE - DESPATCH OF NOTIFICATION AND APPLICATION FORMS

2021-06-30

General Announcement::RIGHTS: OFFER INFORMATION STATEMENT DATED 30 JUNE 2021

2021-06-30

REPL::Rights::Voluntary

2021-06-27

General Announcement::Press Release: iX Biopharma Commences Supply of Medicinal Cannabis Wafers to Brazil

2021-06-22

REPL::Rights::Voluntary

2021-06-21

REPL::Rights::Voluntary

2021-06-14

General Announcement::IX PARTICIPATES IN STUDY: WAFERMINE FOR TREATMENT OF BREAKTHROUGH PAIN IN ADVANCED CANCER PATIENTS

2021-06-08

Rights::Voluntary

2021-06-03

Employee Stock Option/ Share Scheme::GRANT OF SHARE AWARD PURSUANT TO iX PERFORMANCE SHARE PLAN

2021-06-01

General Announcement::Press Release: iX Biopharma Expands Wafer Production Capacity to Meet Growing Demand

2021-05-31

Change - Change of Catalist Sponsor::Change of Continuing Sponsor

2021-05-17

General Announcement::Orphan Drug Designation Granted for the Treatment of CRPS with Ketamine to iX Biopharma

2021-02-28

General Announcement::Press Release: iX Biopharma announces appointment of Director of Corporate Affairs

2021-02-28

Change - Announcement of Appointment::Appointment of Director of Corporate Affairs

2021-02-09

Financial Statements and Related Announcement::Half Yearly Results

2021-02-09

General Announcement::ANNOUNCEMENT PURSUANT TO RULE 706A OF THE CATALIST RULES

2021-01-18

Change - Announcement of Appointment::Appointment of Chief Commercial Officer

© 2025 Dividends.sg / More Countries